Dermaliq Therapeutics

Developer of therapeutics for dermatological indicatications

placeWilmington, Delaware, United States calendar_todayFounded 2018 groups4 employees language dermaliq.com

Registered entities

Innovation

10 patent families (5 granted) — focus: Human necessities; filing pace steady. Cited 868 times.

YearFilings
20172
20181
20191
20201
20211
20225
20235
20244
20252
20264

Investor mix

1 investor on record; lead investors include 3E Bioventures Capital.

Investor typeCountShare
Venture capital1100%
Coming soon